SEC 13F Intelligence

Scientech Research LLC / VRDN

Scientech Research LLC’s Viridian Therapeutics Inc Position

Does Scientech Research LLC own Viridian Therapeutics Inc (VRDN)? Yes — 65.1K shares worth $1M (+1.06% of its 13F portfolio) as of Q1 2026, up from 20.1K shares the prior filed quarter.

Position Value
$1M
Q1 2026
Shares
65.1K
% of Portfolio
+1.06%
Quarters Held
3
currently held

Position History VRDN

Reported value by quarter
Q3 ’24: $611,065Q3 ’24Q4 ’24: $386,141Q4 ’24Q1 ’26: $1MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202665.1K$1M+1.06%
Q4 202420.1K$386,141+0.11%
Q3 202426.9K$611,065+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Scientech Research LLC’s full portfolio or all institutional holders of VRDN.